共 50 条
Validation of the lower urinary tract symptom score
被引:0
|作者:
Blaivas, Jerry G.
[1
,2
,3
]
Tsui, Johnson F.
[2
,4
]
Mekel, Gabriel
[2
,5
]
Benedon, Matthew S.
[2
]
Li, Belinda
[6
]
Friedman, Fara M.
[3
]
Weinberger, James M.
[2
,7
]
Weedon, Jeremy
[3
]
Weiss, Jeffrey P.
[2
,3
]
机构:
[1] Weill Cornell Coll Med, New York, NY USA
[2] Inst Bladder & Prostate Res, New York, NY USA
[3] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[4] North Shore LIJ Lenox Hill Hosp, New York, NY USA
[5] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[6] Loyola Univ, Stritch Sch Med, Chicago, IL 60611 USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词:
patient reported outcomes (PRO);
lower urinary tract symptoms;
questionnaire;
voiding dysfunction;
overactive bladder;
urinary incontinence;
QUALITY-OF-LIFE;
INCONTINENCE IMPACT QUESTIONNAIRE;
UROGENITAL DISTRESS INVENTORY;
OVERACTIVE BLADDER SYMPTOM;
INDEX;
WOMEN;
D O I:
暂无
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Introduction: To develop and validate a lower urinary tract symptom score (LUTSS) as a measure of lower urinary tract symptom (LUTS) severity and a treatment outcome tool in adults. Materials and methods: An expert panel was convened to develop the LUTSS questionnaire. Content validity was achieved by obtaining subject and expert feedback from two prospective drafts. Subjects were divided into three groups: normal, LUTS and overactive bladder (OAB). Questionnaire was administered on two separate occasions within 1-2 weeks. Test-retest reliability, internal consistency, discriminant validity, criterion validity and responsiveness to change were also assessed. Results: The questionnaire contains 14 questions with answers scored on a 5-point Likert scale (0-4). It includes 9 storage, 4 voiding and 1 bother question. One hundred ninety-one patients completed it; 80 males and 111 females, mean age 65 years (range 22-91). Seventy-two had OAB, 91 LUTS without OAB and 28 were normal. Test-retest intraclass correlation was 0.96 and Cronbach's-alpha was 0.77, indicating strong test-retest reliability and internal consistency, respectively. ANOVA and post-hoc bootstrap-generated adjustments showed significant differences between the three groups (p < 0.001), demonstrating discriminant validity. Responsiveness to change was exhibited by the significant decrease between preop and postop scores and a concurrent patient global impression of improvement (PGI-I) score indicative of symptomatic improvement. Conclusion: The 14-question LUTSS is a validated questionnaire that assesses a full range of LUTS in men and women. The ordinal nature of the data with its highly specific description of symptoms makes it ideally suited as a nuanced and comprehensive symptom score and patient reported outcome (PRO) tool.
引用
收藏
页码:7952 / 7958
页数:7
相关论文